Regenstrief announces licensing agreement with Indiana HIE

Calling it an “unprecedented licensing agreement," the medical research organization Regenstrief Institute announced on April 19 that it is licensing its Indiana Network for Patient Care (INPC) and DOCS4DOCS clinical results delivery software to a subsidiary of the Indiana Health Information Exchange (IHIE).

“This licensing agreement represents the single most significant transfer of discovery out of an academic medical informatics research setting to a commercial enterprise in the history of Indiana’s health information technology sector and the national evolution of health information exchange,” according to the announcement, which said it would enable out-of-state expansion for the IHIE subsidiary.

Since 2004, IHIE has been largely responsible for getting 94 Indiana hospitals and 25,000 physicians in 17 states to use the INPC and DOCS4DOCS software while creating a sustainable business model, according to the announcement. “[O]n an average day, [the INPC handles] more than half a million secure transactions of clinically important data--including medical histories, laboratory test results, medication records, treatment reports--in a standardized, electronic format."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.